4DMedical Limited (ASX:4DX) has locked in a three-year contract extension with the prestigious Cleveland Clinic, ensuring continued use of its functional lung imaging software. The deal, valued at a minimum of A$227,000, reflects growing revenue per site and reinforces 4DMedical’s foothold in one of the world’s leading academic medical centres.
Strengthening a Key Partnership
The Cleveland Clinic, consistently ranked among the top three hospitals in the U.S., is a powerhouse in pulmonology research and clinical practice. With 1,000 beds across a sprawling 170-acre main campus in Ohio, the institution plays a pivotal role in shaping healthcare practices, making it a prime partner for 4DMedical’s cutting-edge respiratory imaging solutions.
The extended agreement builds on an existing multi-year contract for 4DMedical’s pulmonary structure products, reinforcing the company’s position as a trusted provider of advanced lung imaging technology.
A Testament to 4DMedical’s Innovation
4DMedical’s Software-as-a-Service (SaaS) platform delivers unparalleled insights into respiratory function, supporting clinicians with superior diagnostic capabilities. The renewal highlights the growing adoption of 4DMedical’s solutions, particularly among top-tier institutions.
CEO and Founder Andreas Fouras expressed confidence in the company’s trajectory, stating:
“We are delighted to extend our collaboration with such a world-class medical institution. The Cleveland Clinic’s continued trust in our technology validates the impact we are making in respiratory health. We also see significant opportunities to expand our footprint within the Cleveland Clinic, particularly with new solutions like CT:VQ™, which have generated strong interest from leading pulmonologists.”
With this contract extension, 4DMedical is well positioned for further expansion in the U.S. and beyond, solidifying its role as a leader in next-generation lung imaging.
